(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 158.68% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.86%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.25%.
Uniqure Nv's revenue in 2026 is $18,672,000.On average, 15 Wall Street analysts forecast QURE's revenue for 2026 to be $1,875,320,948, with the lowest QURE revenue forecast at $1,114,856,974, and the highest QURE revenue forecast at $3,787,406,095. On average, 15 Wall Street analysts forecast QURE's revenue for 2027 to be $6,023,779,218, with the lowest QURE revenue forecast at $1,513,505,743, and the highest QURE revenue forecast at $12,957,645,762.
In 2028, QURE is forecast to generate $25,044,743,053 in revenue, with the lowest revenue forecast at $10,740,695,234 and the highest revenue forecast at $40,867,915,294.